Key result
Aromatic PUFA analogues with a tyrosine head group robustly activate the cardiac IKs channel via hydrogen bonding and ionic interactions, shifting voltage dependence of activation by up to -74.4 mV.
Why the study?
Interventions restoring KV channel function have therapeutic potential in disorders like long QT syndrome, but the mechanisms of IKs channel activation by aromatic PUFA analogues were undetermined.
Population
Cardiac IKs channel complexes formed by KV7.1 and KCNE1
Comparison
Modified aromatic head groups to probe cation-pi interactions, hydrogen bonding, and ionic interactions
Design
In vitro mechanistic study
Authors
Loading...
May support PUFA analogs for arrhythmia therapy; leaves open clinical translation from molecular data.
Effect estimate: ΔV0.5 = -56.2 ± 3.6 mV for NALT at 20 μM
Tyrosine PUFA analogues activate the cardiac IKs channel via hydrogen bonding and ionic interactions, providing mechanistic insights for potential long QT syndrome therapies.
Bohannon et al. (2023) studied Long QT syndrome (in vitro model). Aromatic polyunsaturated fatty acid (PUFA) analogues (e.g., NALT, Lin-tyr) vs. Baseline (0 μM PUFA) or non-aromatic PUFAs was evaluated on Shift in voltage dependence of activation (ΔV0.5) and maximal conductance (Gmax) (ΔV0.5 = -56.2 ± 3.6 mV for NALT at 20 μM). Aromatic PUFA analogues with a tyrosine head group robustly activate the cardiac IKs channel via hydrogen bonding and ionic interactions, shifting voltage dependence of activation by up to -74.4 mV.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: